Table 2.
Twenty percent reduction in symptom severity from baseline at study weeks 2, 4 and 8 as a predictor of response at week 16
Sensitivity | Specificity | Positive Predictive Value | Negative Predictive Value | |
---|---|---|---|---|
Study Week | ||||
Week 2 (n=85) | 51.1 (35.8%–66.3%) | 65 (48.3%–79.4%) | 62.2 (44.8%–77.5%) | 54.2 (39.2%–68.6%) |
Week 4 (n=66) | 61.8 (43.6%–77.8%) | 56.3 (37.7%–73.6%) | 60 (42.1%–76.1%) | 58.1 (39.1%–75.5%) |
Week 8 (n=50) | 65 (40.8%–84.6%) | 50 (31.3%–68.7%) | 46.4 (27.5%–66.1%) | 68.2 (45.1%–86.1%) |